Cite
Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy.
MLA
Marcath, Lauren A., et al. “Genetic Variation in EPHA Contributes to Sensitivity to Paclitaxel‐induced Peripheral Neuropathy.” British Journal of Clinical Pharmacology, vol. 86, no. 5, May 2020, pp. 880–90. EBSCOhost, https://doi.org/10.1111/bcp.14192.
APA
Marcath, L. A., Kidwell, K. M., Vangipuram, K., Gersch, C. L., Rae, J. M., Burness, M. L., Griggs, J. J., Van Poznak, C., Hayes, D. F., Smith, E. M. L., Henry, N. L., Beutler, A. S., & Hertz, D. L. (2020). Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy. British Journal of Clinical Pharmacology, 86(5), 880–890. https://doi.org/10.1111/bcp.14192
Chicago
Marcath, Lauren A., Kelley M. Kidwell, Kiran Vangipuram, Christina L. Gersch, James M. Rae, Monika L. Burness, Jennifer J. Griggs, et al. 2020. “Genetic Variation in EPHA Contributes to Sensitivity to Paclitaxel‐induced Peripheral Neuropathy.” British Journal of Clinical Pharmacology 86 (5): 880–90. doi:10.1111/bcp.14192.